The inaugural bellwether trial in California state courts concerning allegations that Johnson & Johnson’s talcum powder products cause ovarian cancer is scheduled to commence on November 3, 2025, in Los Angeles. This trial is part of a coordinated proceeding addressing numerous lawsuits filed against the company.
Johnson & Johnson has faced a series of legal challenges over its talc-based products. In March 2025, a U.S. bankruptcy judge rejected the company’s $10 billion settlement proposal aimed at resolving these lawsuits, marking the third unsuccessful attempt to address the claims through bankruptcy court. ([reuters.com](https://www.reuters.com/sustainability/boards-policy-regulation/us-judge-rejects-jjs-10-billion-baby-powder-settlement-2025-03-31/?utm_source=openai))
In July 2025, a Massachusetts jury ordered Johnson & Johnson to pay over $42 million to a man who alleged that decades of using the company’s talc products led to his mesothelioma diagnosis. The jury found that the company failed to warn consumers about the risks associated with its talc products. ([reuters.com](https://www.reuters.com/legal/litigation/johnson-johnson-ordered-pay-42m-after-jury-finds-talc-caused-mans-cancer-2025-07-29/?utm_source=openai))
California has been a significant venue for talc litigation. In 2017, a Los Angeles jury awarded $417 million to a woman who developed ovarian cancer after using Johnson & Johnson’s talc-based products. The verdict included $347 million in punitive damages, reflecting the jury’s stance on the company’s conduct. ([courthousenews.com](https://www.courthousenews.com/la-jury-awards-417m-user-johnson-johnson-baby-powder/?utm_source=openai))
As the upcoming bellwether trial approaches, it is expected to provide insights into how juries may respond to the evidence and arguments presented in these cases. The outcome could influence the direction of numerous pending lawsuits and potential settlement discussions.